Research and Development

Partnerships

In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. To partner with us, please contact a representative in one of the following areas:

Human PrescriptionConsumer Health Care
Animal HealthMergers & Acquisitions


Schering-Plough Biopharma

Located adjacent to Stanford University in the vibrant biotech environment of Silicon Valley, Schering-Plough Biopharma was built by legendary innovators. Combining research strengths in oncology and immunology, there is a legacy of pioneering science at Schering-Plough Biopharma that is being translated into medicines for our future.


Schering-Plough Clinical Trials information

Introduction and Disclaimer



 

The IFPMA portal has been designed as a single entry allowing you to search for comprehensive information on on-going clinical trials (registry) or results of completed trials (database) conducted by the innovative pharmaceutical industry.

Global Project Management and Drug Safety



Global Project Management (GPM) includes several functions that focus on our portfolio of R&D projects: project leadership, project management operations, and research alliances (including Discovery alliances and Development alliances).  GPM owns the CCPF process, facilitating the project teams and governance committees across all therapeutic areas to develop projects to their full potential and providing objective strategic direction, planning, and operational expertise.  GPM manages each project with clear vision along the complexity of the development pathway, while building team ownership of each functional role in the integrated plan.

Drug Safety (DS) is made up of a diverse array of scientists whose primary function is to define potential risk to human subjects of serious adverse effects from novel pharmaceutical agents.  By partnering closely with scientists in Discovery, Pharmaceutical Sciences, and Early Clinical Research and Experimental Medicine, scientists in this area generate data on toxicology in preclinical species to enable the safe and rapid exploration of efficacy and safety of new therapeutic agents in human clinical trials.  The data generated by this group form a key part of communications to global regulatory agencies in support of world-wide drug development activities.